Adamis Pharmaceuticals Corp

NASDAQ:ADMP   3:59:19 PM EDT
0.60
-0.01 (-1.08%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)89.74M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$2.82 Million
Adjusted EPS-$0.05
See more estimates
10-Day MA$0.62
50-Day MA$0.73
200-Day MA$0.92
See more pivots

Adamis Pharmaceuticals Corp Stock, NASDAQ:ADMP

11682 El Camino Real, Suite 300, San Diego, California 92130
United States of America
Phone: +1.858.997.2400
Number of Employees: 116

Description

Adamis Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development, and sale of pharmaceutical, specialty biopharmaceutical, and other drug products. The company provides products in various therapeutic areas, including allergy, respiratory, opioid overdose, and erectile dysfunction markets. It offers the SYMJEPI Injection for the emergency treatment of allergic reactions. The company was founded in June 2006 and is headquartered in San Diego, CA.